HUMAN IMMUNOGLOBULIN SHOWING SPECIFICITY TO HUMAN PROTEIN L-SELECTIN

biotechnology. SUBSTANCE: human immunoglobulin showing specificity to human protein L-selectin is chimeric immunoglobulin having regions that determine complementarity (CDR) corresponding to CDR-regions of murine donor immunoglobulin and carcass regions of variable site of heavy and light chain of h...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	KO MAN SUNG
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	biotechnology. SUBSTANCE: human immunoglobulin showing specificity to human protein L-selectin is chimeric immunoglobulin having regions that determine complementarity (CDR) corresponding to CDR-regions of murine donor immunoglobulin and carcass regions of variable site of heavy and light chain of human acceptor immunoglobulin and specifically binding with human L-selectin (affinity constant is 107M-1). Invention ensures to prepare nonimmunogeneous for human immunoglobulin showing specificity to protein L-selectin. EFFECT: improved method of preparing. 19 cl, 1 tbl, 6 dwg, 5 ex